Elinore F McCance-Katz

Summary

Affiliation: Virginia Commonwealth University
Country: USA

Publications

  1. ncbi request reprint Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine
    Elinore F McCance-Katz
    Virginia Commonwealth University, Richmond, USA
    Clin Infect Dis 43:S224-34. 2006
  2. ncbi request reprint Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and delavirdine
    Elinore F McCance-Katz
    Virginia Commonwealth University, Richmond, Virginia 23298, USA
    Am J Addict 15:23-34. 2006
  3. ncbi request reprint Treatment of opioid dependence and coinfection with HIV and hepatitis C virus in opioid-dependent patients: the importance of drug interactions between opioids and antiretroviral agents
    Elinore F McCance-Katz
    Division of Addiction Psychiatry, Virginia Commonwealth University, Richmond, VA 23219, USA
    Clin Infect Dis 41:S89-95. 2005
  4. ncbi request reprint Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir
    Elinore F McCance-Katz
    Virginia Commonwealth University, Richmond, USA
    Clin Infect Dis 43:S235-46. 2006
  5. ncbi request reprint Gender effects following repeated administration of cocaine and alcohol in humans
    Elinore F McCance-Katz
    Medical College of Virginia at Virginia Commonwealth University, Division of Addiction Psychiatry, Richmond, Virginia 23219, USA
    Subst Use Misuse 40:511-28. 2005
  6. ncbi request reprint Office-based buprenorphine treatment for opioid-dependent patients
    Elinore F McCance-Katz
    Division of Addiction Psychiatry, Department of Psychiatry, Virginia Commonwealth University, VA, USA
    Harv Rev Psychiatry 12:321-38. 2004
  7. ncbi request reprint Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and nelfinavir
    Elinore F McCance-Katz
    Medical College of Virginia, Virginia Commonwealth University, PO Box 980109, Richmond, VA 23298, USA
    Am J Addict 13:163-80. 2004
  8. ncbi request reprint The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients
    Elinore F McCance-Katz
    Medical College of Virginia, Virginia Commonwealth University, Richmond, VA 23298, USA
    Clin Infect Dis 37:476-82. 2003
  9. pmc Interaction between buprenorphine and atazanavir or atazanavir/ritonavir
    Elinore F McCance-Katz
    Virginia Commonwealth University, Richmond, VA, USA
    Drug Alcohol Depend 91:269-78. 2007
  10. pmc Interactions between buprenorphine and the protease inhibitors darunavir-ritonavir and fosamprenavir-ritonavir
    Valerie A Gruber
    Department of Psychiatry, University of California San Francisco, CA, USA
    Clin Infect Dis 54:414-23. 2012

Detail Information

Publications31

  1. ncbi request reprint Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine
    Elinore F McCance-Katz
    Virginia Commonwealth University, Richmond, USA
    Clin Infect Dis 43:S224-34. 2006
    ..Adjustments of doses of either buprenorphine or EFV or DLV are not likely to be necessary when these drugs are administered for the treatment of opiate dependence and HIV disease...
  2. ncbi request reprint Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and delavirdine
    Elinore F McCance-Katz
    Virginia Commonwealth University, Richmond, Virginia 23298, USA
    Am J Addict 15:23-34. 2006
    ....
  3. ncbi request reprint Treatment of opioid dependence and coinfection with HIV and hepatitis C virus in opioid-dependent patients: the importance of drug interactions between opioids and antiretroviral agents
    Elinore F McCance-Katz
    Division of Addiction Psychiatry, Virginia Commonwealth University, Richmond, VA 23219, USA
    Clin Infect Dis 41:S89-95. 2005
    ..This promising finding may simplify the treatment of opioid-dependent patients with HIV disease and should also improve clinical outcomes for persons coinfected with HIV and hepatitis C virus...
  4. ncbi request reprint Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir
    Elinore F McCance-Katz
    Virginia Commonwealth University, Richmond, USA
    Clin Infect Dis 43:S235-46. 2006
    ..Adjustments of doses of either buprenorphine or NFV, LPV/R, or RTV are not likely to be necessary when these drugs are administered for the treatment of opioid dependence and HIV disease...
  5. ncbi request reprint Gender effects following repeated administration of cocaine and alcohol in humans
    Elinore F McCance-Katz
    Medical College of Virginia at Virginia Commonwealth University, Division of Addiction Psychiatry, Richmond, Virginia 23219, USA
    Subst Use Misuse 40:511-28. 2005
    ..This double-blind, placebo-controlled, randomized study examined gender differences in response to administration of these drugs alone and in combination...
  6. ncbi request reprint Office-based buprenorphine treatment for opioid-dependent patients
    Elinore F McCance-Katz
    Division of Addiction Psychiatry, Department of Psychiatry, Virginia Commonwealth University, VA, USA
    Harv Rev Psychiatry 12:321-38. 2004
    ....
  7. ncbi request reprint Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and nelfinavir
    Elinore F McCance-Katz
    Medical College of Virginia, Virginia Commonwealth University, PO Box 980109, Richmond, VA 23298, USA
    Am J Addict 13:163-80. 2004
    ..While no toxicities were observed, clinicians should be aware of the potential for drug interactions when patients require treatment with nelfinavir and these opiate medications...
  8. ncbi request reprint The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients
    Elinore F McCance-Katz
    Medical College of Virginia, Virginia Commonwealth University, Richmond, VA 23298, USA
    Clin Infect Dis 37:476-82. 2003
    ..Lopinavir is a potent inducer of methadone metabolism, and treatment with L/R requires clinical monitoring and increased methadone doses in some patients, whereas ritonavir has no significant effect on methadone metabolism...
  9. pmc Interaction between buprenorphine and atazanavir or atazanavir/ritonavir
    Elinore F McCance-Katz
    Virginia Commonwealth University, Richmond, VA, USA
    Drug Alcohol Depend 91:269-78. 2007
    ..Atazanavir or atazanavir/ritonavir may increase buprenorphine and buprenorphine metabolite concentrations and might require a decreased buprenorphine dose...
  10. pmc Interactions between buprenorphine and the protease inhibitors darunavir-ritonavir and fosamprenavir-ritonavir
    Valerie A Gruber
    Department of Psychiatry, University of California San Francisco, CA, USA
    Clin Infect Dis 54:414-23. 2012
    ..This study examined drug interactions between buprenorphine, a partial opioid agonist used for opioid dependence treatment and pain management, and the protease inhibitors (PIs) darunavir-ritonavir and fosamprenavir-ritonavir...
  11. ncbi request reprint Acute cocaine responses following cocaethylene infusion
    Jennifer Baker
    Virginia Commonwealth University, Richmond, Virginia, USA
    Am J Drug Alcohol Abuse 33:619-25. 2007
    ..Agonist substitution therapy may have potential as an alternative treatment for cocaine dependence...
  12. pmc Lack of clinically significant drug interactions between nevirapine and buprenorphine
    Elinore F McCance-Katz
    Department of Psychiatry, University of California, San Francisco, California, USA
    Am J Addict 19:30-7. 2010
    ..Buprenorphine did not alter nevirapine pharmacokinetics. Dose adjustments of either buprenorphine or nevirapine are not likely to be necessary when these drugs are coadministered for the treatment of opiate dependence and HIV disease...
  13. pmc Interactions between buprenorphine and antiretrovirals: nucleos(t)ide reverse transcriptase inhibitors (NRTI) didanosine, lamivudine, and tenofovir
    Jennifer Baker
    Department of Psychiatry, Virginia Commonwealth University, Richmond, Virginia, USA
    Am J Addict 19:17-29. 2010
    ..Buprenorphine had no significant effect on NRTI concentrations. Concomitant use of buprenorphine with ddI, 3TC, or TDF results in neither a significant pharmacokinetic nor pharmacodynamic interaction...
  14. pmc Untreated HIV infection is associated with higher blood alcohol levels
    Elinore F McCance-Katz
    Department of Psychiatry, Addiction Medicine Research, University of California San Francisco, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 60:282-8. 2012
    ..This pilot study examines the relationship of untreated HIV infection to blood alcohol concentrations (BAC) relative to BAC after initiation of antiretroviral therapy (ART)...
  15. ncbi request reprint Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients
    Alison Oliveto
    Department of Psychiatry, Yale School of Medicine and the VA CT Healthcare System, West Haven, CT, USA
    Drug Alcohol Depend 79:157-65. 2005
    ..These results suggest that an efficacious maintenance dose is necessary for contingencies to be effective in facilitating both opioid and cocaine abstinence...
  16. ncbi request reprint Interactions between alcohol and the HIV entry inhibitor Maraviroc
    Valerie A Gruber
    Department of Psychiatry, University of California San Francisco, San Francisco, CA, USA
    J Int Assoc Provid AIDS Care 12:375-7. 2013
    ..The present study evaluated the effects of alcohol on maraviroc pharmacokinetics and the effects of maraviroc on alcohol pharmacokinetics...
  17. pmc Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review
    Elinore F McCance-Katz
    Department of Psychiatry, University of California, San Francisco, San Francisco, California, USA
    Am J Addict 19:4-16. 2010
    ..A substantial literature has accumulated on drug interactions between either methadone or buprenorphine with other medications when ingested concomitantly by humans. This review summarizes current literature in this area...
  18. pmc Disulfiram effects on responses to intravenous cocaine administration
    Jennifer R Baker
    Virginia Commonwealth University, Division of Addiction Psychiatry, P O Box 980109, Richmond, VA 23219, USA
    Drug Alcohol Depend 87:202-9. 2007
    ..Disulfiram has been studied as a treatment for cocaine dependence. We report results of a randomized, double-blind, placebo-controlled, within-subject study to examine the interaction of disulfiram with intravenous cocaine...
  19. ncbi request reprint Effect of buprenorphine and antiretroviral agents on the QT interval in opioid-dependent patients
    Jennifer R Baker
    Addiction Psychiatry, Virginia Commonwealth University, Richmond, 23298, USA
    Ann Pharmacother 40:392-6. 2006
    ....
  20. ncbi request reprint Medical illness and comorbidities in drug users: implications for addiction pharmacotherapy treatment
    Joy C Draper
    Department of Obstetrics and Gynecology, Virginia Commonwealth University School of Medicine, Richmond, Virginia 23219, USA
    Subst Use Misuse 40:1899-921, 2043-8. 2005
    ..We conclude with a brief review of models of care that have been effective in addressing the needs of this challenging population that can provide additional means for enhancing the clinical care of substance users...
  21. doi request reprint Effect of cocaine use on methadone pharmacokinetics in humans
    Elinore F McCance-Katz
    Department of Psychiatry, University of California San Francisco, San Francisco, California, USA
    Am J Addict 19:47-52. 2010
    ..09) and more rapid methadone clearance (p = .08). Regular cocaine use may adversely impact treatment outcomes for opioid dependence in those receiving methadone maintenance by decreasing methadone exposure...
  22. doi request reprint Effect of cocaine use on buprenorphine pharmacokinetics in humans
    Elinore F McCance-Katz
    Department of Psychiatry, University of California San Francisco, San Francisco, California, USA
    Am J Addict 19:38-46. 2010
    ..Regular cocaine users were younger (p = .0007), and used more heroin (p = .004) and cocaine (p < .0001). Regular cocaine use may result in lower buprenorphine plasma concentrations with potential for adverse clinical outcomes...
  23. ncbi request reprint Modified directly observed therapy (MDOT) for injection drug users with HIV disease
    Elinore F McCance-Katz
    Departments of Psychiatry, Epidemiology and Social Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA
    Am J Addict 11:271-8. 2002
    ..The authors conclude that MDOT is a promising intervention for the treatment of IDUs with HIV disease, though significant drug interactions must be monitored for carefully and rapidly addressed...
  24. ncbi request reprint Introduction to special issue "addiction pharmacotherapy and special populations"
    Elinore F McCance-Katz
    Division of Addiction Psychiatry, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA
    Subst Use Misuse 40:1895-7. 2005
  25. ncbi request reprint A brief overview of the clinical pharmacology of "club drugs"
    Gena Covell Britt
    Division of Addiction Psychiatry, Virginia Commonwealth University, Richmond, Virginia 23219, USA
    Subst Use Misuse 40:1189-201. 2005
    ..The neurobiology, clinical pharmacology, and treatment issues for each are discussed...
  26. ncbi request reprint Well-intentioned, but potentially spreading the virus
    Elinore F McCance-Katz
    Subst Use Misuse 38:2127-9. 2003
  27. pmc Sex differences in cocaine-dependent individuals' response to disulfiram treatment
    Charla Nich
    Yale University School of Medicine, VA Connecticut Health Care System, West Haven, USA
    Addict Behav 29:1123-8. 2004
    ..Reasons for this apparent sex-based response are not clear, but possible mechanisms worthy of greater study include differences in alcohol use by sex as well as differences in dopamine-mediated responses to cocaine and disulfiram...
  28. ncbi request reprint The pharmacokinetics of methadone following co-administration with a lamivudine/zidovudine combination tablet in opiate-dependent subjects
    Petrie M Rainey
    Yale University School of Medicine, New Haven, Conn, USA
    Am J Addict 11:66-74. 2002
    ..3 +/- 61.0 vs. 35.0 +/- 17.5 h) were detected. These results suggest that methadone dose change is not likely to be necessary for patients treated with lamivudine/zidovudine combination pharmacotherapy...
  29. ncbi request reprint Novel metabolites of buprenorphine detected in human liver microsomes and human urine
    Yan Chang
    University of Utah, Center for Human Toxicology, Department of Pharmacology and Toxicology, 417 Wakara Way, Suite 2111, Salt Lake City, UT 84108, USA
    Drug Metab Dispos 34:440-8. 2006
    ..Examination of human urine from subjects taking buprenorphine showed the presence of M1 and M3; most of M1 was conjugated, whereas 60 to 70% of M3 was unconjugated...
  30. ncbi request reprint Buprenorphine assay and plasma concentration monitoring in HIV-infected substance users
    Robin DiFrancesco
    Pharmacotherapy Research Center, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, NY, USA
    J Pharm Biomed Anal 44:188-95. 2007
    ..Use of this combined BUP and ARV plasma concentration monitoring approach for a representative patient receiving BUP, atazanavir and efavirenz demonstrated its clinical application...
  31. ncbi request reprint The in vivo glucuronidation of buprenorphine and norbuprenorphine determined by liquid chromatography-electrospray ionization-tandem mass spectrometry
    Wei Huang
    Center for Human Toxicology, Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84108, USA
    Ther Drug Monit 28:245-51. 2006
    ..Because urinary elimination is limited ( approximately 11% of daily dose), the role of NBUPG in total clearance of buprenorphine is not yet known...